Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dachshund family transcription factor 1 (DACH1) is a chromatin-associated transcription factor encoded by the DACH1 gene on chromosome 13q22. It contains conserved domains similar to Drosophila dachshund and Ski protein family members, with broad expression in multiple tissues. DACH1 plays key roles in development (especially of the eye, kidney, and neural tissues), cell fate determination, and gene regulation. In adults, DACH1 functions predominantly as a tumor suppressor by repressing cell proliferation, migration, and EMT, and by modulating hormone receptor signaling (including estrogen and androgen receptor pathways). Loss of DACH1 expression is linked to tumor progression in several solid cancers and is associated with poor prognosis. It is also implicated in renal development/disease, chromosomal rearrangements in leukemia, and metabolic regulation in the liver[1][2][3].
Not directly drug-targeted; mechanisms involve modulation of gene transcription, co-repressor recruitment, inhibition of oncogenic and hormone receptor signaling, repression of cell cycle proteins (e.g., Cyclin D1)[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dachshund family transcription factor 1 (DACH1).